Shinichi Koizumi
Directeur/Bestuurslid bij TSUBOTA LABORATORY INCORPORATED
Actieve functies van Shinichi Koizumi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Directeur/Bestuurslid | 01-06-2020 | - |
| Independent Dir/Board Member | 01-06-2020 | - | |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Directeur/Bestuurslid | 01-01-2013 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | - | |
| Corporate Officer/Principal | 01-01-2013 | - |
Loopbaan van Shinichi Koizumi
Eerdere bekende functies van Shinichi Koizumi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RAQUALIA PHARMA INC. | Directeur/Bestuurslid | 14-07-2011 | 01-08-2014 |
| Hoofd Techniek/Wetenschap/O&O | 14-07-2011 | 29-11-2012 | |
| Corporate Officer/Principal | - | - |
Opleiding van Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Japan | 5 |
Operationeel
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Beurs
- Insiders
- Shinichi Koizumi
- Ervaring
